News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Roche and Labcyte Inc. Integrate Echo and LightCycler Systems to Increase Performance of qPCR-based RNA/DNA Analyses
December 6, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SUNNYVALE, Calif.--(BUSINESS WIRE)--Roche (SIX: RO, ROG; OTCQX: RHHBY) and Labcyte Inc. will cooperate around high-speed, miniaturized quantitative PCR (qPCR) to monitor the expression of tens to thousands of genes for therapeutic research.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Roche
MORE ON THIS TOPIC
Funding
Biohaven Seeks $150 Million From Wall Street Following FDA Rejection
November 12, 2025
·
3 min read
·
Dan Samorodnitsky
Layoffs
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program
November 12, 2025
·
2 min read
·
Tristan Manalac
Business
Phase III Fail Forces Neuphoria Into Strategic Review—With One Investor Offering a Takeover
November 12, 2025
·
1 min read
·
Tristan Manalac
Layoffs
Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset
November 10, 2025
·
2 min read
·
Dan Samorodnitsky